Concepedia

Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

Ioannis Zachos, Panagiotis A. Konstantinopoulos, Gerasimos P. Vandoros, Michalis V. Karamouzis, Athanasios Papatsoris, Thomas Podimatas, Antonios Papachristodoulou, Michael Chrisofos, Charalambos Deliveliotis, Athanasios G. Papavassiliou

Journal of Cancer Research and Clinical Oncology · 2009 · 16 citations · 28 references

DOIFull text

Open access

Concepts

References

28

DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS?

Harry W. Herr, Pramod C. Sogani · The Journal of Urology · 2001 · 384 citations

, , +10

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

Harry W. Herr, David M. Schwalb, Zuo‐Feng Zhang et al. · Journal of Clinical Oncology · 1995 · 303 citations

, , +17

Superficial Bladder Cancer Treated with Bacillus Calmette-Guerin: A Multivariate Analysis of Factors Affecting Tumor Progression

Harry W. Herr, Robert A. Badalament, David A. Amato et al. · The Journal of Urology · 1989 · 246 citations

, , +13

Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.

Kai Kraemer, Susanne Fuessel, U. Schmidt et al. · PubMed · 2003 · 135 citations

, , +14

The Nucleolar Localization Domain of the Catalytic Subunit of Human Telomerase

Katherine T. Etheridge, Soma S. R. Banik, Blaine N. Armbruster et al. · Journal of Biological Chemistry · 2002 · 133 citations · Full text

, , +13